Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin-A in Temporomandibular Myofascial Pain
NCT07668375Phase 4Completed
- Sponsor
- PAEC General Hospital
- Start
- Jan 2026
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in temporomandibular joint disorder (TMJ), sponsored by PAEC General Hospital. Started Jan 2026; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
temporomandibular joint disorder (TMJ)
Beyond the preview
Go deeper on NCT07668375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668375.